Effective treatment of neurodegenerative and neurological diseases remains a high unmet need. This problem is only set to grow in size as the population ages; if left unchecked, more than 12 million people will be struggling with neurodegenerative diseases in the United States alone by 2050.
Incidence of neurodegenerative disease in United States. Source: Harvard NeuroDiscovery Center
• University of Georgia, Professor & Director, Regenerative Bioscience Center • Co-Founder, Former CSO and CEO of Advanced Cell Technology and Cytogenesis Inc. • 30 years of research work in stem cells and exosomes.
• >20 years of process development, cell manufacturing and business development experience • Directed first commercialized hPSC neural cell line at Aruna Bio • Expertise in process management.
• >15 years of experience in the pharmaceutical industry • 10 years as President, CEO, & Chairman, EyeGate Pharmaceuticals, Inc.(NASDAQ: EYEG) • Expertise in corporate finance